3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Carcinoma, Hepatocellular
10
Pancreatic Neoplasms
9
Neoplasm Metastasis
5
Breast Neoplasms
5
Melanoma
4
Colorectal Neoplasms
4
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Lymphoma
3
Lung Neoplasms
3
Liver Neoplasms
3
Carcinoma, Renal Cell
3
Wilms Tumor
2
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Neuroblastoma
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasms
2
Kidney Neoplasms
2
Astrocytoma
2
Adenomatous Polyposis Coli
2
Thyroid Neoplasms
1
Thrombocytosis
1
Somatostatinoma
1
Sarcoma, Clear Cell
1
Retinoblastoma
1
Interventions
Granulocyte Colony-Stimulating Factor
5
Thiotepa
4
Melphalan
3
Filgrastim
3
Busulfan
3
Topotecan
2
Mesna
2
Ifosfamide
2
Etoposide
2
Carboplatin
2
sargramostim
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
omburtamab I-131
1
etoposide phosphate
1
cixutumumab
1
Ursodeoxycholic Acid
1
Stem Cell Transplantation
1
Sirolimus
1
Simvastatin
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Peripheral Blood Stem Cell Transplantation
1
Paclitaxel
1
Leukapheresis
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Cyclophosphamide
1
Bone Marrow Transplantation
1
Arsenic Trioxide
1
Amifostine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Retinoblastoma
×
Sirolimus
×
Gastrointestinal
×
Clear all
NCT01331135
2020-05-29
Aflac ST0901
Emory University
Phase 1
Completed
18 enrolled